Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical …
Background The prognosis of invasive mucinous adenocarcinoma (IMA) remains
controversial and should be clarified by comparison with the International Association for the …
controversial and should be clarified by comparison with the International Association for the …
[HTML][HTML] Prognosis in resected invasive mucinous adenocarcinomas of the lung: related factors and comparison with resected nonmucinous adenocarcinomas
Abstract Introduction In the 2015 World Health Organization classification, invasive
mucinous adenocarcinoma (IMA) is categorized as one of various subtypes of lung invasive …
mucinous adenocarcinoma (IMA) is categorized as one of various subtypes of lung invasive …
[HTML][HTML] Primary invasive mucinous adenocarcinoma of the lung: prognostic value of CT imaging features combined with clinical factors
Objective To investigate the association between CT imaging features and survival
outcomes in patients with primary invasive mucinous adenocarcinoma (IMA). Materials and …
outcomes in patients with primary invasive mucinous adenocarcinoma (IMA). Materials and …
[HTML][HTML] Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study
SW Moon, SY Choi, MH Moon - Journal of thoracic disease, 2018 - ncbi.nlm.nih.gov
Background In 2015, the World Health Organization (WHO) announced a new classification
of lung tumors. Mucinous bronchioloalveolar adenocarcinomas were reclassified as …
of lung tumors. Mucinous bronchioloalveolar adenocarcinomas were reclassified as …
Clinical course of stage IV invasive mucinous adenocarcinoma of the lung
Introduction An invasive mucinous adenocarcinoma (IMA) is a distinct lung adenocarcinoma
variant. The characteristics of stage IV IMAs are relatively unclear since most previous …
variant. The characteristics of stage IV IMAs are relatively unclear since most previous …
Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma
D Cui, S Xie, Q Liu - BMC Pulmonary Medicine, 2023 - Springer
Abstract Purpose In 2015, the World Health Organization renamed mucinous
bronchioloalveolar adenocarcinoma as pulmonary invasive mucinous adenocarcinoma …
bronchioloalveolar adenocarcinoma as pulmonary invasive mucinous adenocarcinoma …
Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis
T Zhao, J Yi, D Luo, J Liu, X Fan, Q Wu… - World Journal of Surgical …, 2024 - Springer
Background Invasive mucinous adenocarcinoma of the lung (IMA) is a unique and rare
subtype of lung adenocarcinoma with poorly defined prognostic factors and highly …
subtype of lung adenocarcinoma with poorly defined prognostic factors and highly …
Limited resection is comparable to lobectomy for tumor size≤ 2 cm pulmonary invasive mucinous adenocarcinoma
W Lin, H Su, H Xie, L Xu, T Wang, L Wang, X Hu… - World Journal of …, 2024 - Springer
Objectives Invasive mucinous adenocarcinoma (IMA) has a rare incidence with better
prognosis than nonmucinous adenocarcinoma. We aimed to investigate the prognosis …
prognosis than nonmucinous adenocarcinoma. We aimed to investigate the prognosis …
Comparison of surgical outcomes between invasive mucinous and non-mucinous lung adenocarcinoma
T Matsui, N Sakakura, S Koyama, K Nakanishi… - The Annals of Thoracic …, 2021 - Elsevier
Background Invasive mucinous adenocarcinoma (IMA) is a rare subtype of invasive lung
adenocarcinoma. However, the clinical course and prognostic outcomes following IMA …
adenocarcinoma. However, the clinical course and prognostic outcomes following IMA …
[HTML][HTML] Nomogram for predicting prognosis and identifying chemotherapy beneficiaries for completely resected stage I invasive mucinous lung adenocarcinoma
H He, X Zeng, Q Zhang, W Hu, R Huang… - Translational Lung …, 2024 - ncbi.nlm.nih.gov
Background At present, there is a lack of studies in invasive mucinous adenocarcinoma
(IMA) that combine clinicopathological and imaging features to stratify risk and select optimal …
(IMA) that combine clinicopathological and imaging features to stratify risk and select optimal …